Monday
Oct052015
NCT02576145
Immune Response to Neoantigen and Recall Antigen in Pediatric Renal Transplant Recipients Treated With the IL-2R Alfa Monoclonal Antibody, Daclizumab (Zenapax®)
Sponsor: Hoffman-La Roche
Condition: Kidney Transplantation
Phase 4